Article

High-Cost Branded Drug Prescribing Trend Highlights AJPB Week in Review

Author(s):

Davy James, Managing Editor

Top articles of the week from The American Journal of Pharmacy Benefits.

Related Videos
Related Content
Gout tophus, photomicrograph showing amorphous, eosinophilic material with a foreign-body giant cell reaction and inflammation
April 25th 2025

JAK1 Inhibitor NS-229 Granted FDA Orphan Drug Designation to Treat Allergic Autoimmune Condition

Luke Halpern, Assistant Editor
Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education
February 28th 2025

Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education

Luke Halpern, Assistant Editor Jill Simonian, PharmD Codi Peterson, PharmD, MS
Antibody (Ab), also known as an immunoglobulin (Ig). 3d vector.
April 24th 2025

Intravenous Immunoglobulin Does Not Improve Clinical Outcomes Compared With Tocilizumab in Severe COVID-19

Luke Halpern, Assistant Editor
Pharmacy Focus: World Psychedelics Day
June 14th 2024

Pharmacy Focus: World Psychedelics Day

Ashley Gallagher, Editor
Image of kidneys without fibrosis -- Image credit: Itsaree | stock.adobe.com
April 24th 2025

Type 5 Collagen Linked to Kidney Scarring, Offers New Treatment Hope for Patients With CKD

Gillian McGovern, Associate Editor
Gene editing in chronic hepatitis B -- Image credit: 红 王 | stock.adobe.com
April 22nd 2025

PBGENE-HBV Granted FDA Fast Track Designation for Chronic Hepatitis B

Gillian McGovern, Associate Editor